The document discusses how venture capital deals are similar to romantic relationships, going through stages from initial meetings and courting to engagement, marriage, and potential divorce. It outlines Psilos Investment Model which focuses on later stage healthcare companies that can lower costs and improve quality. The document also discusses deal sourcing, due diligence processes, term sheets, post-investment responsibilities like board participation, managing future financings, and helping portfolio companies exit through M&A, IPO or other means.
The Triple Threat | Article on Global Resession | Harsh Kumar
Healthcare innovation deals guide
1. 2011 Copyright by Lisa Suennen Innovation in Healthcare - Haas School of Business Meet, Fall in Love, Then What? How Doing a Venture Deal is Like a Relationship
3. How a Venture Deal is Like a Relationship Dating Scene The Courting Phase Engagement & the Prenuptual Agreement Building the Family Golden Anniversary Things go badly Break up Things go badly Break up Things go badly Divorce Deal Due Term Due Deal Portfolio Positive or Identification Diligence Sheet Diligence Closing Management Negative Exit Things go well Marriage Things go well Things go well Things go well Defining Your Perfect Match The Pick-Up
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
Editor's Notes
My focus today is to tell you how a deal gets done, from search to exit What I mean by exit is when you, the investor, cash out your shares in the company through their sale to another company or after an IPO; these are the principal ways that a venture fund makes money
As I was thinking about my presentation, I wanted to come up with a simple paradigm for what we do and what occurred to me is this: Venture deals are just like relationships…. You cast around and see lots and lots of ideas, from the sublime to the ridiculous You fall in love, and believe me, you do fall in love with deals. You break up if the engagement doesn ’t go as planned or you get “married” and have what is often an 5-10 year business relationship; or You argue, even when you still love each other You deal with the stress of daily life and see the stretch marks and gray hair that didn ’t seem to be there before and work around it; sometimes others join the family as you need new investors You either grow old and meet the end smiling or kicking and screaming. Every one of these stages is present in a venture deal.
Don ’t forget: what am I NOT looking for
As you develop your investment model, there are a few other considerations to bear in mind There is a major bifurcation in healthcare investment: Bio-tech/pharma model: Life saving drugs will be paid for Not economically sensitive Highly binary outcome: the molecule works or it doesn’t A few “home-runs” more than return the fund Not much the VC can do while the science happens Generally requires the public market or a major strategic partner to get the product to market financially Healthcare model More incremental businesses than discovery of new molecule Highly economically sensitive Potential for all companies to make it, theoretically Likely broad array of outcomes resulting in the returns More focus on business operations, revenue, profitability Should be more capital efficient You have sold your investors on a targeted return and timeline…this drives your thinking on a number of fronts, particularly risk management
Example: OmniGuide Focus : medical devices Model : enables surgeries that could not be done and does some surgeries in a much cheaper and more effective way (e.g., brain surgery, stapes surgery) Stage : product launch Structure : invested $17mm of a $27mm round so we have majority in that round and have voting rights to control many aspects going forward Ownership : board member, manage hiring committee, audit committee, actively introduce them to customers and bankers and industry leaders
Generally true that a known source is the best source Active Health InSound Medical Sometimes you are surprised by what comes from elsewhere Example: Soccer dad brought me Estech Revolution Health brought us Extend Health Portfolio company brought us Click4Care
So now you have your target, and frankly, this is where the hard work starts. You have to prove to yourself and, more challenging, your partners, that you are right about your hunch. For Psilos, it is usually 12-16 weeks from identification of a hot deal (to us) to closing.
Now you are in the dating phase, where you are basically sniffing each other out and poring over every nook and cranny of that company. Due diligence means looking at everything they say and do and figuring out what works, what doesn ’t and what can be done to improve their prospects. It is also the time for really getting to know management, how responsive they are, how honest they are and, do you really want to work with these people. The truth is, every great company has some pretty crappy times-can you work with these people side by side for the next 7 years, because you will be. Don ’t fall prey to conventional wisdom as you enter due diligence But don ’t ignore your gut feelings
Hand out a sample term sheet. Generally we give a term sheet when we are ready to say to ourselves: we think we want to do this deal—time to prove to ourselves that there is a reason not to do it. Eg—Gamma Medica—most recent deal; talked for months before we gave them terms…tested first..etc. I will point out some highlights, but the main things to remember is, this is the road map for the ultimate relationship, the rules of the road not just for making the investment, but for managing it and exiting it…a critical document. The first road test of the relationship. Gives you the opportunity to really test the mettle and style of management and the board.
I am not going to go over it in extensive detail because it would take an hour or more. If there are people who want to hear that, I can set up time to do it another day. Equity and Debt Valuation Capitalization and investment amount Terms of the security Preferred Participating preferred Convertible Seniority Future rounds of financing…what happens Preemptive rights Antidilution Voting rights
As in any relationship, sometimes you wake up and say to yourself, I have to get the hell out of here . The due diligence process is designed exactly to help you figure out if there is reason to run. Sometimes you find out information that leads you to renegotiate the deal . The most important thing to ask yourself during those times is: if I had known this day 1, would I have given them a term sheet. If not, then run. One of the tools I find very useful is background checks. I have them fill out a paper form by hand where they have to write true or false to a number of questions. Then I do a full background check. I am amazed at some of the stuff I have seen over the years. Resume doesn ’t match what they told you Bankruptcy Gambling debts Don ’t take shortcuts—EXAMPLE: Canopy Health Raised over $88mm in venture capital (Foundation, Spectrum, Granite Global) $9mm in 2007 revenue; $60mm in 2008 Tax statements and audits were bogus (6 months after close Fatal error: not speaking with the accountants Don ’t fall in love with falling in love…know when your live one is a dead duck
Certificate =basic document that lists all the capital stock and its terms, board construct, what happens on liquidation, voting rights, lays out Board construct, conversion, anti-dilution, etc. Purchase Agreement =what you are buying for how much and what is being represented to you as part of that sale ( Schedule of Exceptions ) Shareholder Agreement =Board voting, stock transfers, tags and drags, etc. Investor Rights Agreement =special rights, such as registration rights, protective provisions, inspection, pre-emptive rights, rights of information, insurance, Management Rights = basically meets Dept of Labor requirements enabling you to engage with portfolio companies and maintain your VC standing Indemnification = company indemnifies board member for lawsuit
It is amazing to me, considering how much money VCs invest, how few of them actively shepherd their investment . We have found that a successful outcome directly correlates to activism on the part of the investors. It ’s like a family…if the parents don’t pay attention, the kids can go off the reservation. Don ’t be a drive by board member . Act like you own the place , because you do! And since it ’s your place too, keep it running well . Help management identify and solve problems. Be a resource. You aren’t there to run the place or take the role of management over, but you are their to help steer the course, apply your experience and keep everyone honest and looking forward . EXAMPLE: introduced a portfolio company to a new client recently—SeeChange; OmniGuide Don ’t forget the importance of long range planning . Too many boards get caught up in the quarter and forget it’s a long ride. It is critical to actively speak about product road map, capital needs, management succession, etc. even when it is allegedly too early too worry about those things. It is never too early. Example: Patient Safe CEO change For instance: Spend three years bringing a product to market and then look up and realize they don ’t have a “next product” but the ultimate exit value is significantly enhanced if you are not just a one trick pony.
If there is one universal truth in venture capital it is: it will take longer and need more money than anyone originally thought. A critical part of being a board member and investor is thinking about the next round well in advance of its occurrence Before that a critical piece of running a fund is RESERVE STRATEGY Example: Capital reserves for Patient Safe Solutions
At the end of a deal ’s life, you want to be the guy on the left, not the guy on the right. The guy on the left exited at the value peak for his company, meeting his IRR objectives. The guy on the right got forced to exit because he ran out of money and the predators swept in and blew the investors away. These things happen all the time. There is some luck involved in a good exit, but you mostly make your own luck. This is the main reason that activism as a board member and investor is so critical. You can stop the train wreck, often, through great leadership and planning (give HealthEdge example ).
At this stage of the game, you are the Mom hoping to ensure your daughter marries well. Part of it is teaching the skills to be ready when the time comes and to make sure she knows that you want her to marry rich! Part of it is being honest about her flaws so you can teach her to present her best side. Some of it is about protecting your own interests…this is the time when everyone ’s true colors really come out….it is amazing how mis-aligned the incentives of everyone involved can be. EXAMPLE: InSound VC ’s want to exit because they need some points on the board and others don’t because they don’t like the price Mgmt doesn ’t want to exit because they will have to find another job, or Management wants to exit because they will walk away with $$ VC ’s don’t want to exit because there is still huge value creation in front of you It is important to keep everyone ’s incentives reasonably aligned or at least as out in the open as possible.
So here we are at Berkeley so I thought I could get away with getting a little “ideological” on you. Since we are in healthcare, which allegedly has some “greater good” associated with it, what is our responsibility to consider that greater good when we invest? Is it acceptable to back a new drug when you know it has potentially dangerous side effects? Is it acceptable to back a new medical device when you know it is no better than one already out there but costs more? Is it acceptable to foster a new healthcare service that costs a lot but doesn ’t really improve quality of care, such as old school disease management? Is it ok to support a new product that payers love but which makes physicians ’ lives more complicated thus reduces their time with patients?